1. Cushman, D.W., Cheung, H.S., Sabo, E.F. and Ondetti, M.A. Design of potent competitive inhibitors of angiotensin converting enzyme. Carboxy-alkanoyl and mercaptoalkanoyl amino acids. Biochemistry 16: 54–84 (1977)
2. Vinci, J.M., Horwitz, D., Zusman, R.M., Pisano, J.J., Catt, K.J. and Keiser, H.R. The effect of converting enzyme inhibition with SQ20881 on plasma and urinary kinins,prostaglandin E,and angiotensin II in hypertensive man. Hypertension 1: 416–426 (1979)
3. Iimura, O., Shimamoto, K., Tanaka, S., Hosoda, S., Nishitani, T., Ando, T., and Masuda, A. The mechanism of the hypotensive effect of Captopril (converting enzyme inhibitor) with special reference to the kallikrein-kinin and renin-angiotensin systems. JapJ.Med.25: 34–39 (1986)
4. McCaa, R.E., Hall, J.E. and McCaa, C.S. The effects of angiotensin-I converting enzyme inhibitors on arterial blood pressure and urinary sodium excretion. Role of the renal renin-angiotensin and kallikrein-kinin systems. Circ Res.(Suppl.I) 43: 32–39 (1978)
5. Shimamoto, K., Ando, T., Tanaka, S., and Iimura, O. The determination of kinin and glandular kallikrein in human biological fluids. Allergologie: in press (1987)